corilagin has been researched along with Liver Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Chen, Y; Huang, S; Kong, W; Kuang, S; Lv, Z; Wang, F; Wang, Y; Wu, C; Xie, S; Zeng, T; Zheng, R; Zhou, C | 1 |
| Chen, L; Deng, Y; Huang, W; Li, X; Ming, Y; Tong, Q; Zheng, Z | 1 |
| Chen, L; Liu, S; Ming, Y; Tong, Q; Yu, Y; Zheng, G; Zheng, Z | 1 |
| Chui, CH; Gambari, R; Hau, DK; Wong, WY | 1 |
| Chan, KW; Cheng, CH; Cheng, GY; Cheung, F; Chui, CH; Fong, DW; Gambari, R; Hau, DK; Lai, PB; Lam, KH; Lau, FY; Leung, AK; Tong, SW; Wong, RS; Wong, WY; Zhu, GY | 1 |
5 other study(ies) available for corilagin and Liver Neoplasms
| Article | Year |
|---|---|
Corilagin alleviates liver fibrosis in zebrafish and mice by repressing IDO1-mediated M2 macrophage repolarization.
Topics: Animals; Liver Cirrhosis; Liver Neoplasms; Macrophages; Mice; Tumor Microenvironment; Zebrafish | 2023 |
Corilagin induces the apoptosis of hepatocellular carcinoma cells through the mitochondrial apoptotic and death receptor pathways.
Topics: Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Hydrolyzable Tannins; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Signal Transduction | 2018 |
Corilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrest.
Topics: Animals; Carcinoma, Hepatocellular; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cisplatin; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; G2 Phase Cell Cycle Checkpoints; Glucosides; Humans; Hydrolyzable Tannins; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |
Sensitization of Hep3B hepatoma cells to cisplatin and doxorubicin by corilagin.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Synergism; Glucosides; Humans; Hydrolyzable Tannins; Liver Neoplasms; Mice; Mice, Nude; Xenograft Model Antitumor Assays | 2014 |
In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Glucosides; Humans; Hydrolyzable Tannins; Liver; Liver Neoplasms; Mice; Mice, Nude; Phytotherapy; Plant Extracts; Xenograft Model Antitumor Assays | 2010 |